10-102878429-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_020682.4(AS3MT):c.661C>A(p.Gln221Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000229 in 1,614,012 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_020682.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
AS3MT | NM_020682.4 | c.661C>A | p.Gln221Lys | missense_variant | 8/11 | ENST00000369880.8 | |
BORCS7-ASMT | NR_037644.1 | n.1066C>A | non_coding_transcript_exon_variant | 12/15 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
AS3MT | ENST00000369880.8 | c.661C>A | p.Gln221Lys | missense_variant | 8/11 | 1 | NM_020682.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152042Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000321 AC: 8AN: 249510Hom.: 0 AF XY: 0.0000517 AC XY: 7AN XY: 135360
GnomAD4 exome AF: 0.0000239 AC: 35AN: 1461852Hom.: 0 Cov.: 31 AF XY: 0.0000385 AC XY: 28AN XY: 727226
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152160Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74382
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 06, 2024 | The c.661C>A (p.Q221K) alteration is located in exon 8 (coding exon 8) of the AS3MT gene. This alteration results from a C to A substitution at nucleotide position 661, causing the glutamine (Q) at amino acid position 221 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at